AzTrials
AzTrials

Subthreshold DepressionNCT07880652

Dietary Education Intervention for Subthreshold Depression (MIND-Trial)

A study testing Mediterranean-Style Dietary Education Program and Befriending in people with Subthreshold Depression, run by Institute of Mental Health, Singapore at 1 site in Singapore.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This randomized controlled trial evaluates the efficacy of an 8-week dietary education intervention in adults with subthreshold depression. Participants will be randomly assigned in a 1:1 ratio to either a dietary education intervention or a befriending control condition. Read more about this study

Who is it for?
Ages 21 to 60 years
Conditions the study is for
Subthreshold Depression
What is being tested?
Mediterranean-Style Dietary Education Program and Befriending
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteSingapore
Study dates
Oct 2026to Dec 2028
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male or female, aged 21 to 60 years.
  • Meets the operational diagnostic criteria for subthreshold depression.
  • Has not been following a Mediterranean-style diet, based on self-report and a - Mediterranean Diet Adherence Screener (MEDAS) score ≤9.
  • Able to converse in English.
  • Able to use a computer or mobile device with internet access.
  • Capable of providing informed consent.

Who cannot join

  • Current use of antidepressants, antipsychotics, or mood stabilizers.
  • Self-reported lifetime diagnosis of bipolar disorder, a psychotic disorder, an eating disorder, or a current substance use disorder.
  • Major life trauma, such as recent bereavement or job loss, within the preceding 3 months.
  • Current participation in an intervention targeting diet.
  • Severe food allergies, intolerances, or aversions.
  • Unwilling to accept a Mediterranean-style diet.
Show all 12Show fewer
  • Current daily or regular use of over-the-counter or prescription probiotic/prebiotic supplements.
  • Systemic oral or intravenous antibiotic use within 30 days before the study.
  • Self-reported chronic gastrointestinal disorder, including inflammatory bowel disease, irritable bowel syndrome, or celiac disease.
  • Self-reported history of significant gastrointestinal surgery, such as gastric bypass or bowel resection.
  • Self-reported systemic autoimmune disease or active chronic infectious disease.
  • Currently pregnant or lactating, or planning pregnancy during the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Singapore1 site
  • Institute of Mental Health

    Singapore, 539747

    Jiangbo Ying, 65+63892000, jiangbo.john.ying@nhghealth.com.sg

Other trials in Singapore

About this study

Official title: Microbiome in Depression: A Dietary Education Intervention Trial on the Microbiome and Subthreshold Depression (MIND-Trial)

This randomized controlled trial evaluates the efficacy of an 8-week dietary education intervention in adults with subthreshold depression. Participants will be randomly assigned in a 1:1 ratio to either a dietary education intervention or a befriending control condition. The dietary intervention consists of online dietary education and counseling designed to encourage a Mediterranean dietary pattern. The control group will receive online befriending sessions of similar frequency and duration. The study will evaluate changes in depressive symptoms and investigate changes in oral and gut microbiota, dietary measures, psychiatric symptoms, metabolic measures, and neurobiological markers.

Read the detailed description

Subthreshold depression is characterized by clinically significant depressive symptoms that do not meet the full diagnostic criteria for major depressive disorder and represents an important opportunity for early intervention.

Emerging evidence suggests that diet and the gut microbiome may be involved in mental health through the microbiota-gut-brain axis. However, evidence regarding dietary interventions specifically for individuals with subthreshold depression is limited, particularly in Asian populations, and the mechanisms linking dietary changes with depressive symptoms remain incompletely understood.

The MIND-Trial is an 8-week, parallel-group, open-label randomized controlled trial involving 64 adults with subthreshold depression. Participants will be randomized 1:1 to a dietary education intervention or a befriending control condition.

Participants assigned to the intervention will receive online dietary education and counseling every two weeks, incorporating tailored dietary recommendations and structured goal setting to encourage a Mediterranean dietary pattern. Participants assigned to the control condition will receive online befriending sessions at the same frequency and duration, involving conversations on neutral topics.

The study will evaluate depressive symptoms as well as dietary adherence, other psychiatric and gastrointestinal symptoms, anthropometric measures, oral and gut microbiota, metabolites, and neurobiological markers.

Being tested
Mediterranean-Style Dietary Education Program, Befriending
Keywords
Subthreshold depression, Subclinical depression, Dietary intervention, Mediterranean diet, Gut microbiome, Oral microbiome, Nutritional psychiatry, Microbiota-gut-brain axis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mediterranean-Style Dietary Education ProgramBehavioural

    An 8-week online dietary education and counseling program delivered every two weeks, incorporating tailored dietary recommendations and structured goal setting to encourage adoption of a Mediterranean dietary pattern.

  • BefriendingBehavioural

    Online befriending sessions delivered at the same frequency and duration as the dietary education intervention. Sessions consist of conversations on neutral topics intended to maintain engagement and control for nonspecific factors such as attention, treatment expectancy, and engagement.

Study groups in NCT07880652
Study groupRoleWhat they receive
Dietary Education InterventionExperimentalParticipants will receive an online dietary education program delivered via Microsoft Teams by qualified dietitians or trained research staff every two weeks over an 8-week period. Sessions will incorporate internet-delivered dietary education, counseling, tailored dietary recommendations, and structured goal setting to encourage a Mediterranean dietary pattern. Participants will receive a S$25 grocery voucher and a list of Mediterranean foods every two weeks.
Receives: Behavioral: Mediterranean-Style Dietary Education Program
Befriending ControlActive comparatorParticipants will receive befriending sessions via Microsoft Teams at the same frequency and duration as the dietary education sessions. Researchers will engage participants in conversations on neutral topics such as hobbies, books, music, and sports. Participants will receive a S$25 grocery voucher every two weeks and will be advised to continue their usual grocery shopping habits.
Receives: Behavioral: Befriending

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Depressive Symptoms Assessed by the Center for Epidemiologic Studies Depression Scale (CES-D)

    Depressive symptoms will be assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item self-report measure with a total score ranging from 0 to 60. Higher scores indicate greater severity of depressive symptoms (i.e., a worse outcome). Change in CES-D score from baseline will be compared between the dietary education intervention and befriending control groups.

    Measured: Baseline to Week 8

Secondary outcomes (5)
  1. Change in Depressive Symptoms Assessed by the Patient Health Questionnaire-9 (PHQ-9)

    Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 consists of 9 items and has a total score ranging from 0 to 27. Higher scores indicate greater severity of depressive symptoms (i.e., a worse outcome).

    Measured: Baseline through Week 8

  2. Change in Insomnia Symptoms Assessed by the Insomnia Severity Index (ISI)

    Insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). The ISI consists of 7 items and has a total score ranging from 0 to 28. Higher scores indicate greater severity of insomnia symptoms (i.e., a worse outcome).

    Measured: Baseline through Week 8

  3. Change in Anxiety Symptoms Assessed by the Beck Anxiety Inventory (BAI)

    Anxiety symptoms will be assessed using the Beck Anxiety Inventory (BAI). The BAI consists of 21 items and has a total score ranging from 0 to 63. Higher scores indicate greater severity of anxiety symptoms (i.e., a worse outcome).

    Measured: Baseline through Week 8

  4. Change in Autistic Traits Assessed by the Autism-Spectrum Quotient (AQ)

    Autistic traits will be assessed using the Autism-Spectrum Quotient (AQ). The AQ consists of 50 items and has a total score ranging from 0 to 50 using the standard binary scoring method. Higher scores indicate a greater level of autistic traits.

    Measured: Baseline through Week 8

  5. Change in Mediterranean Diet Adherence Assessed by the Mediterranean Diet Adherence Screener (MEDAS)

    Adherence to a Mediterranean dietary pattern will be assessed using the Mediterranean Diet Adherence Screener (MEDAS). The MEDAS consists of 14 items and has a total score ranging from 0 to 14. Higher scores indicate greater adherence to a Mediterranean dietary pattern (i.e., a better outcome).

    Measured: Baseline through Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionOct 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07880652
Sponsor's protocol ID
2026-0119
Status last verified
Oct 2026
First submitted
28 Sep 2026
Last updated
19 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in